Riskpilot← Back to searchSign inGet full accessCochlear Nordic AB
ABActiveOrg 5566461330Konstruktionsvägen 14Wholesale of pharmaceutical and medical goods · NACE 4646Est. 200336 employees
Revenue 2025
SEK 72,2M
+21% vs 2024
EBITDA margin
9.0%
+24% vs 2024
Equity ratio
27.2%
Financial strength
Net profit 2025
SEK 5,2M
+31% vs 2024
| Revenue | SEK 72,2M | +21% |
| EBITDA | SEK 6,5M | +24% |
| Net profit | SEK 5,2M | +31% |
| Total assets | SEK 22,2M | -33% |
| Equity | SEK 6,1M | -67% |
| Employees | 36 | — |
Legal name
Cochlear Nordic AB
Org number
5566461330
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
8 juli 2003
Share capital
SEK 100 000
Employees
36 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna Firman tecknas ensam av Vedholm, Charlotta Sofia
Company purpose
Bolaget skall ha till föremål för sin verksamhet att utveckla, tillverka, marknadsföra, sälja och bedriva distributions- och agentverksamhet avseende medicinsk utrustning och medicintekniska produkter, att äga och förvalta värdepapper samt att bedriva därmed förenlig verksamhet.
Address
Konstruktionsvägen 14
Phone
+46313351461
Email
nordic@cochlear.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 57 484 | 67 363 | 37 098 | 43 253 | 52 157 | 56 779 | 59 794 | 72 240 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 2 865 | 2 689 | 5 264 | 2 788 | 2 769 | 3 207 | 4 278 | 5 420 | 5 248 | 6 494 |
| Depreciation & amort. | −61 | −71 | −63 | −132 | −163 | −196 | −327 | −218 | −183 | −181 |
| EBIT | 2 804 | 2 618 | 5 201 | 2 656 | 2 606 | 3 011 | 3 951 | 5 202 | 5 065 | 6 313 |
| Net financials | 75 | 4 | −5 | — | −6 | −7 | −53 | 6 | 20 | 4 |
| Profit before tax | 2 879 | 2 621 | 5 196 | 2 656 | 2 601 | 3 005 | 3 898 | 5 208 | 5 085 | 6 317 |
| Tax | −652 | −596 | −1 214 | −678 | −699 | −675 | −884 | −1 137 | −1 081 | −1 077 |
| Net profit | 2 227 | 2 025 | 3 982 | 1 978 | 1 902 | 2 330 | 3 014 | 4 071 | 4 004 | 5 240 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 13 661 | 15 069 | 23 524 | 14 511 | 14 193 | 16 240 | 21 698 | 27 629 | 33 259 | 22 245 |
| Equity | 7 540 | 9 565 | 13 547 | 2 524 | 4 426 | 6 756 | 9 771 | 13 842 | 18 097 | 6 059 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 6 121 | 5 504 | 9 977 | 11 986 | 9 767 | 9 484 | 11 927 | 13 788 | 15 162 | 16 185 |
| Total debt | 6 121 | 5 504 | 9 977 | 11 986 | 9 767 | 9 484 | 11 927 | 13 788 | 15 162 | 16 185 |
EBITDA margin
9.0%
This company
15.8%
Market median
-43% vs market
20162025
Equity ratio
27.2%
This company
38.2%
Market median
-29% vs market
20162025
Return on equity
86.5%
This company
18.4%
Market median
+370% vs market
20162025
Net profit margin
7.3%
This company
8.1%
Market median
-10% vs market
20162025
Asset turnover
3.25×
This company
1.12×
Market median
+190% vs market
20162025
Debt / equity
2.67×
This company
0.62×
Market median
-331% vs market
20162025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-07-01 – 2016-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CS External Signatory | External Signatory | 2020 | — | — |
TG Chief Auditor | Chief Auditor | 2020 | — | — |
FD Chief Auditor | Chief Auditor | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2020 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
COCHLEAR EUROPE LTD | Company | 100.0% | 100.0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
COCHLEAR EUROPE LTD
Cochlear Nordic AB (this company)Board members of Cochlear Nordic AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Charlotta Sofia Vedholm | External Signatory | 0 companies |
| Thord Gösta Fredrik Axelsson | Chief Auditor | 0 companies |
| Filip David Larsson | Chief Auditor | 0 companies |
| Brent Andrew Cubis | Chairman | 0 companies |
| Peter Bart J Van Gerwen | Board of Directors | 0 companies |
| Johan Daniel Land | Board of Directors | 0 companies |
| Anna Maria Thérése Helling | Board of Directors | 0 companies |
| Rom Hillel Mendel | Board of Directors | 0 companies |
| Diggory William Howitt | Chairman | 0 companies |